CSIMarket



Johnson and Johnson  (JNJ)
Other Ticker:  
 

Johnson And Johnson's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Jul 03 2022)
II. Quarter
(Apr 03 2022)
I. Quarter
(Jan 02 2022)
IV. Quarter
(Oct 03 2021)
III. Quarter
(Jul 04 2021)
II. Quarter
Y / Y Equity Change 9.74 % 13.48 % 16.98 % 8.99 % -
Y / Y Net Income Change -23.32 % -16.91 % 172.5 % 3.18 % 73.14 %
Net Income (TTM) in Millions 18,366 19,830 20,878 17,880 17,767
Return On Equity (TTM) 24.87 % 27.49 % 29.86 % 26.59 % 27.01 %
Total Ranking # 696 # 619 # 588 # 621 # 621
Equity (TTM) in Millions 76,357 74,709 74,023 70,272 69,580
Seq. Equity Change 2.21 % 0.93 % 5.34 % 0.99 % 5.69 %
Seq. Net Income Change -6.51 % 8.72 % 29.15 % -41.59 % 1.31 %


Roe Comment
Johnson and Johnson returned in II. Quarter 24.87 % on shareholder's equity, and it was higher than Johnson And Johnson average return on equity.

ROE decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 67 other companies have achieved higher return on equity. While Return on equity total ranking has deteriorated compare to previous quarter from 623 to 698.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 30
Sector # 68
Overall # 696

Return On Equity Statistics
High Average Low
29.86 %
23.09 %
1.85 %
(Jan 02 2022)  


Annual Return On Equity (Jan 02 2022)
2021
(Jan 03 2021)
2020
(Dec 29 2019)
2019
(Dec 30 2018)
2018
(Dec 31 2017)
2017
Total Equity in Millions 74,023 63,278 59,471 59,752 60,160
Y / Y Equity Change 16.98 % 6.4 % -0.47 % -0.68 % -14.57 %
Net Income in Millions 20,878 14,714 15,119 15,297 1,300
Y / Y Net Income Change 41.89 % -2.68 % -1.16 % 1076.69 % -92.14 %
Return On Equity 28.2 % 23.25 % 25.42 % 25.6 % 2.16 %





Annual Roe Comment
In 2021 ROE improved to 28.2 % compare to previous year, due to net income growth.


Financial Statements
Johnson And Johnson's Equity $ 76,357 Millions JNJ's Balance sheet
Johnson And Johnson's Income $ 4,814 Millions Quarterly JNJ's Income Statement
JNJ's Income by Division See JNJ's Income by Division

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
JNJ's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for JNJ's Competitors
Return On Equity for Johnson And Johnson's Suppliers
Roe for JNJ's Customers

You may also want to know
JNJ's Roa JNJ's Inventory Turnover Ratio JNJ's Growth Rates JNJ's Dividend Statistics
JNJ's Profitability Ratios JNJ's Asset Turnover Ratio JNJ's Dividend Growth
JNJ's Roi JNJ's Valuation Ratios JNJ's Financial Strength Ratios JNJ's Dividend Payout Ratio



Companies with similar Return On Equity at Jul 03 2022, within Healthcare Sector ROE
Oncotelic Therapeutics Inc.  68.05 %
Biofrontera Inc.  65.87 %
Eli Lilly And Company  64.62 %
Iteos Therapeutics Inc.  60.26 %
180 Life Sciences Corp.  59.53 %
Vyne Therapeutics Inc.  54.91 %
Siga Technologies Inc  48.79 %
Glucotrack Inc.  47.72 %
Reflect Scientific Inc  47.53 %
National Research Corporation  45.39 %
Zoetis Inc.  45.24 %
Prophase Labs Inc.  43.98 %
Merck and Co. Inc.  41.90 %
Enact Holdings Inc.  41.81 %
Innoviva Inc.  38.87 %
Cryo cell International Inc.  38.23 %
Chemed Corporation  37.40 %
Quidelortho Corp  36.94 %
Pfizer Inc  36.26 %
Hanger inc.  34.41 %
Lftd Partners Inc.  33.22 %
Exelixis Inc.  32.88 %
Chemomab Therapeutics Ltd.  32.70 %
Hologic Inc  32.61 %
Fulgent Genetics Inc.  32.32 %
Agenus Inc  31.52 %
Organogenesis Holdings Inc.  31.48 %
Medpace Holdings Inc.  30.56 %
Vertex Pharmaceuticals Inc  30.09 %
Regeneron Pharmaceuticals Inc.  29.68 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ALRN's Profile

Stock Price

ALRN's Financials

Business Description

Fundamentals

Charts & Quotes

ALRN's News

Suppliers

ALRN's Competitors

Customers & Markets

Economic Indicators

ALRN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071